Infanrix IPV inj. susp. i.m. pre-filled syr.

Riik: Belgia

keel: inglise

Allikas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Toimeaine:

Diphtheria Toxoid (DT) >= 30 IU/dose; Poliovirus Type 2 (inactivated) 8 D-antigen U/0,5 ml; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/0,5 ml; Tetanus Toxoid >= 40 IU/dose; Bordetella Pertussis Toxoid (PT) 25 µg/dose; Bordetella Pertussis Pertactin 8 µg/dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/0,5 ml

Saadav alates:

GlaxoSmithKline Biologicals SA-NV

ATC kood:

J07CA02

INN (Rahvusvaheline Nimetus):

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Ravimvorm:

Suspension for injection

Koostis:

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Manustamisviis:

Intramuscular use

Terapeutiline ala:

Diphtheria-Pertussis-Poliomyelitis-Tetanus

Toote kokkuvõte:

CTI code: 212152-02 - Pack size: 10 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 212152-01 - Pack size: 1 dose (0.5 (0.5) - Commercialisation status: NO - FMD code: 05400571000808 - CNK code: 1552215 - Delivery mode: Medical prescription

Volitamisolek:

Commercialised: Yes

Loa andmise kuupäev:

2000-03-13